LPAR3 and diabetes mellitus: Liu et al., found significant differences in the expression of lysophosphatidic acid receptor 3 (LPAR3) and calponin (CNN1) in the peripheral blood leukocytes of patients with DR and DM, thereby suggesting that LPAR3 and CNN1 could be used as biomarkers for DR diagnosis.